Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
HRTX compared with KNSA: revenue, margins and what each company keeps, and the suppliers and customers both name
HRTX
Heron Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
KNSA
Kiniksa Pharmaceuticals International, plc
Change
Mkt cap
Revenue
Revenue
vs
Compare
HRTX
Heron Therapeutics, Inc.
vs
KNSA
Kiniksa Pharmaceuticals International, plc
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
HRTX, solid
KNSA, dashed
HRTX
Heron Therapeutics, Inc.
Change
0.29
▲
+3.30%
Mkt cap
$54.1M
Revenue
$38M
Q2 FY26
Revenue
$155M
FY25
KNSA
Kiniksa Pharmaceuticals International, plc
Change
95.50
▲
+2.37%
Regular session
Nov 4 '26
Mkt cap
$7.3B
Revenue
$286M
Q3 FY26
Revenue
$678M
FY25
vs
Compare
Regular session
Nov 4 '26
HRTX
Heron Therapeutics, Inc.
vs
KNSA
Kiniksa Pharmaceuticals International, plc
0.29
▲
+3.30%
Price
95.50
▲
+2.37%
$54.1M
Mkt cap
$7.3B
Q2 FY26
$38M
Revenue
$286M
Q3 FY26
FY25
$155M
Revenue
$678M
FY25
Change
Change
HRTX
0.29
▲
+3.30%
vs
KNSA
95.50
▲
+2.37%
Regular session
Nov 4 '26